Search Results 671-680 of 17438 for Causal

1. Academics - Find a Program at Mayo Clinic College of Medicine & Science

   Type: Fellowship; Duration: 1 year; School: Graduate Medical Education; Specialty: Laboratory Medicine & Pathology ...

2. A Study to Evaluate if Blood and Spinal Fluid can be used for Future Tests to Diagnose, Treat and Give Prognosis to Patients with Inflammatory Central Nervous System (CNS) Diseases - Mayo Clinic

   A Study to Evaluate if Blood and Spinal Fluid can be used for Future Tests to Diagnose, Treat and Give Prognosis to Patients with Inflammatory Central Nervous ...

3. Study Of BLU-808 In Chronic Inducible Urticaria (CIndU) And Chronic Spontaneous Urticaria (CSU) - Mayo Clinic

   This is a 2-part, proof-of-concept study to be conducted globally, designed to evaluate the safety, tolerability, clinical activity, pharmacokinetics, and ...

4. A StudyStudy of Healthcare Provider Perceptions on Family Caregivers in Clinical Practice

   About this study. This study seeks to understand providers' perspectives on integrating a routine caregiver assessment tool into clinical practice.

5. A Study of Using Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients with Acute Myeloid Leukemia Who Are Undergoing Chemotherapy - Mayo Clinic

   This randomized phase III trial studies caspofungin acetate to see how it works compared to fluconazole in preventing invasive fungal infections in patients ...

6. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

   A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with ...

7. Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System

   About this study. To evaluate the efficacy and safety of the CryoBalloon Focal Ablation System for the treatment of previously-untreated ("treatment naïve") ...

8. Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer - Mayo Clinic

   Monoclonal antibodies, such as atezolizumab and bevacizumab, may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy, such ...

9. Head and neck cancers - Doctors and departments - Mayo Clinic

   Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

10. A Study to Compare Cabozantinib versus Sunitinib to Treat Metastatic Variant Histology Renal Cell Carcinoma Patients - Mayo Clinic

    Cabozantinib and sunitinib are both FDA approved and commercially available for the treatment of advanced kidney cancer, including vhRCC. Participation ...